cornellbreastcenter.com
Weill Cornell Researchers: Copper Depletion Therapy Keeps High-Risk Triple-Negative Breast Cancer at Bay
Researchers at Weill Cornell Medical College have recently published the results of a Phase II clinical trial conducted at the Weill Cornell Breast Center. The results show that an anti-copper drug…